Bucelipase alfa(CAS: 9026-00-0)

Bucelipase alfa (CAS: 9026-00-0) is an enzyme produced by recombinant DNA technology. It is primarily used in the treatment of lipase deficiency to aid in the digestion of fats and proteins. Bucelipase alfa is a glycoprotein with a molecular weight of approximately 30 kDa and consists of a single polypeptide chain with a carbohydrate moiety.

Bucelipase alfa (CAS: 9026-00-0) is mainly used for the treatment of patients with lipase deficiency. It helps in the breakdown of dietary fats and proteins, thus improving the nutritional status of patients with this condition. It is also used in clinical trials for its potential therapeutic applications.

Bucelipase alfa (CAS: 9026-00-0) is generally safe when used as prescribed. However, it is important to follow the dosage instructions and monitor for any adverse reactions. Allergic reactions and gastrointestinal side effects are the most common, but severe allergic reactions require immediate medical attention.

Bucelipase alfa (CAS: 9026-00-0) should be stored below 25°C to maintain its stability. It should be kept in a tightly sealed container and protected from light. Do not freeze the product as freezing may affect its efficacy. Proper storage conditions ensure its effectiveness for patient use.